| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Arieti | 94 | 10% |
| Examiner Bretz | 0 | 0% |
| Examiner Gibbs | 390 | 55% |
| Examiner Konopka | 123 | 39% |
| Examiner Mcleod | 2 | 0% |
| Examiner Meyering | 18 | 11% |
| Examiner Ryan | 29 | 21% |
| Examiner Shin | 469 | 23% |
| Examiner Shukla (SPE) | 28 | 4% |
| Examiner Skibinsky | 202 | 46% |
| Examiner Sullivan | 15 | 0% |
| Examiner Yu | 0 | 0% |
| Art Unit 1635 | 1370 | 35% |
| Number | Class Description |
|---|---|
| 514 | Drug, bio-affecting and body treating compositions |
| 435 | Chemistry: molecular biology and microbiology |
| 536 | Organic compounds -- part of the class 532-570 series |
| 424 | Drug, bio-affecting and body treating compositions |
| 702 | Data processing: measuring, calibrating, or testing |
| 703 | Data processing: structural design, modeling, simulation, and emulation |
| 506 | Combinatorial chemistry technology: method, library, apparatus |
| 800 | Multicellular living organisms and unmodified parts thereof and related processes |
| 530 | Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof |
| 714 | Error detection/correction and fault detection/recovery |
Art Unit 1635's grant rate is lower than that of Group 1630 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1635, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.